Resistance to Ciprofloxacin in urinary infections in patients hospitalized in the medicinainterna service
Abstract
Introduction: Urinary tract infections (UTI) are one of the most frequent infectious processes worldwide. The estimated incidence of UTI in our country is currently unknown. The treatment will depend on the age, the sex, the isolated germ, among others. Fluoroquinolones have been considered as the ideal treatment in this infection. The most empirically used is ciprofloxacin; however, its resistance makes a marked decrease in the effectiveness of the treatment with this agent. Objective: To describe the microbial resistance to ciprofloxacin in UTI as first-line treatment. Methods: Descriptive, cross-sectional and retrospective study, through the review of clinical records of 217 patients, who had the diagnosis of UTI, with reported cultures, during the period January 2013 to December 2017. Results: 82 patients were included (37.76%). The main germs that reported resistance were Escherichia coli (54.23%), Pseudomonas aeruginosa (11.86%). The most frequent comorbidity was Diabetes Mellitus. And the bacterial resistance reported in this study is 79.66%. Discussion: Resistance to ciprofloxacin constitutes a serious public health problem due to its frequent use. E coli were the bacterium with the greatest resistance to this antibiotic, superior to the reviewed studies. The proportion of resistance exceeds that reported in other works. Conclusion: Resistance to ciprofloxacin in urinary tract infection caused by common uropathogens is increasing. The use of this antibiotic agent as…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 217 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.